Overcoming hurdles: measurement of health-related outcomes associated with national level medicines usage in Ireland

Drugs in Context

article

Gary L O’Brien¹  Muireann McAlister²  Stephen Byrne¹  James Gallagher² 

[1] Pharmaceutical Care Research Group, School of Pharmacy, University College Cork, College Road;Pfizer Healthcare Ireland, 9 Riverwalk, National Digital Park, Citywest Business Campus

关键词: drug utilisation;    Health Economics;    life years gained;    number of patients treated;    pharmacoeconomics;    quality-adjusted life years;   

DOI  :  10.7573/dic.2020-4-2

学科分类：社会科学、人文和艺术（综合）

来源: C S F Medical Communications Ltd.

【 摘 要 】

Public discourse on medicine provision predominantly focuses on overall expenditure. However, current literature suggests measurement of alternative indicators can provide a method to benchmark or ameliorate medicine provision. Previous research has investigated the viability of using health-related outcome metrics, such as the number of patients treated, quality-adjusted life-year gain and life-year gain, to provide macro-level estimates on medicines’ societal contributions. This editorial provides an overview of the evolving healthcare landscape surrounding medicine usage estimation and valuation in Ireland and offers recommendations on how improved methods of measuring health-related outcomes may help ameliorate efficiencies and the sustainability of a healthcare system.

【 授权许可】

CC BY-NC-ND